Introduction – Addressing Core Industry Pain Points
The global cosmetics, pharmaceutical, and nutraceutical industries face a persistent sourcing challenge: securing high-purity squalene—a triterpene with antioxidant, moisturizing, and immune-regulating properties—without relying on shark liver extraction, which faces increasing regulatory restrictions (EU REACH, CITES considerations) and consumer backlash against animal-derived ingredients. Manufacturers and formulators increasingly demand vegetable-sourced squalene derived from olives, amaranth seeds, sugarcane, wheat germ, or rice bran, offering identical chemical structure with superior sustainability and ethical positioning. Global Leading Market Research Publisher QYResearch announces the release of its latest report “Vegetable–sourced Squalene – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Vegetable–sourced Squalene market, including market size, share, demand, industry development status, and forecasts for the next few years.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart) 】
https://www.qyresearch.com/reports/6011525/vegetable—sourced-squalene
Market Sizing & Growth Trajectory
The global market for Vegetable–sourced Squalene was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of % from 2026 to 2032. According to QYResearch’s interim tracking (January–June 2026), the market is driven by: (1) tightening restrictions on shark fishing and shark-derived ingredients (EU REACH amendments, potential CITES Appendix II listing for key shark species), (2) explosive growth of “vegan beauty” and “clean beauty” segments (estimated 15-20% annual growth in premium skincare), and (3) expanding pharmaceutical applications (vaccine adjuvants, drug delivery carriers). Olive-sourced squalene dominates (>60% of volume), followed by amaranth seed, sugarcane, wheat germ, and rice bran.
独家观察 – From Shark Liver to Plant Extraction: A Sustainability Imperative
Vegetable-sourced squalene refers to naturally derived squalene extracted from plant-based raw materials. Its chemical composition (C30H50, six double bonds) matches traditional shark liver-derived squalene (deep-sea shark species: Centrophorus, Squalus), offering identical functional properties while eliminating overfishing concerns (an estimated 30-50 million sharks killed annually for squalene at peak). Key plant sources and yields:
| Source | Typical Squalene Content | Extraction Method | Key Players |
|---|---|---|---|
| Olive | 0.3-0.7% (olive oil deodorizer distillate) | Molecular distillation | EFP BIOTEK, Clariant, Sophimix |
| Amaranth Seed | 5-8% (seed oil) | Supercritical CO2 | YiChun Dahaigui, Vestan |
| Sugarcane | 0.1-0.3% (bagasse/soapstock) | Solvent extraction | Amyris (fermentation hybrid), Nucelis |
| Wheat Germ | 0.2-0.5% | Cold pressing + distillation | Kishimoto, Koster Keunen |
| Rice Bran | 0.3-0.6% | Molecular distillation | Zhejiang Lvchuang, Shanghai Lvyuan |
From a discrete manufacturing perspective (batch-based extraction and purification), plant-sourced squalene requires source material selection, oil extraction (pressing or solvent), saponification, and high-vacuum molecular distillation (180-220°C, <0.01 mbar) to achieve >90% purity. This contrasts with bioengineered squalene from microbial fermentation (continuous manufacturing potential), which Amyris pioneered using engineered Saccharomyces cerevisiae.
Six-Month Trends (H1 2026)
Three trends reshape the market: (1) Supercritical CO2 extraction adoption – Leading producers (EFP BIOTEK, Clariant, Nikkol, Croda, Evonik, Givaudan) are investing in supercritical CO2 systems, eliminating solvent residues and achieving 95-98% purity; (2) Chinese producer expansion – YiChun Dahaigui Life Science, Zhejiang Lvchuang Bio-Tech, Hubei Hongfuda Biotechnology, Shanghai Lvyuan Biotechnology, and Guangdong Natural Biological Products are scaling capacity (estimated 30-40% increase since 2024) for domestic cosmetics and export markets; (3) Vaccine adjuvant demand recovery – Post-pandemic, interest in MF59-like adjuvants (squalene-based) for influenza and emerging vaccines has renewed, driving pharmaceutical-grade squalene demand.
User Case Example – Clean Beauty Skincare Line, Europe
A French premium skincare brand launched a “100% vegan, shark-free” anti-aging serum formulated with olive-sourced squalene (EFP BIOTEK supply, 98% purity) in September 2025. By March 2026 (six months post-launch): 85,000 units sold; revenue €4.2 million; brand perception scores for “sustainable” improved from 3.8/10 to 8.2/10; the product won two clean beauty industry awards. The brand is now expanding squalene use across three additional product lines.
Technical Challenge – Low Natural Yields & Extraction Efficiency
A key technical hurdle is plants’ naturally low squalene content (typically 0.1%-0.7%), limiting mass production and keeping costs elevated (vegetable-sourced squalene: $150-300/kg vs. shark-derived $50-100/kg historically). Olive-sourced squalene utilizes olive oil deodorizer distillate (a byproduct), improving economics. Molecular distillation must balance temperature (avoiding thermal degradation) with throughput. Smaller producers lacking optimized distillation columns face higher costs (18-25% of revenue vs. 10-15% for leaders). Additionally, bioengineered squalene from microbial fermentation (Amyris, Nucelis) achieved $50-80/kg production costs by 2025, presenting disruptive competitive pressure if scaled further.
Regulatory & Policy Landscape
Two developments impact the market: (1) EU REACH restrictions (2025-2026) – Updated regulations on shark-derived squalene imports (traceability, CITES documentation) have increased compliance costs, favoring vegetable-sourced alternatives; (2) China “Vegan Cosmetics” labeling guidance (March 2026) – New voluntary certification for plant-derived ingredients, including squalene, allows “vegan” claims for qualified products, potentially boosting domestic demand.
Downstream Demand & Competitive Landscape
Applications: Cosmetics (>65% of volume, moisturizers, anti-aging serums, lip care), Pharmaceuticals (vaccine adjuvants, drug delivery for anticancer agents, topical formulations), Food (nutraceuticals, dietary supplements). Key players: YiChun Dahaigui, Amyris, EFP BIOTEK, Clariant, Kishimoto, Vestan, Sophia Botanicals, Koster Keunen, Nucelis, Vantage Specialty Ingredients, Sophimix, Croda, Evonik, Nikkol, Givaudan, Zhejiang Lvchuang, Hubei Hongfuda, Shanghai Lvyuan, Guangdong Natural Biological. Risks include raw material supply fragility (climate impact on olives/amaranth), high production costs limiting scale economies, and synthetic biology competition (microbial fermentation). Future development may integrate plant extraction with microbial fermentation approaches to balance sustainability, cost, and purity.
Segmentation Summary
The Vegetable–sourced Squalene market is segmented as below:
Segment by Type – Olive-sourced (dominant), Amaranth Seed-sourced, Wheat Germ-sourced, Rice Bran-sourced, Others (sugarcane, etc.)
Segment by Application – Cosmetics (largest), Pharmaceuticals (fastest-growing), Food (nutraceuticals)
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
